3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer -

Blacks have poorer survival rate for skin cancer

CancerJun 22, 06

Researchers have found that among patients suffering from melanomas, those from a black or Hispanic background were more likely than whites to have the advanced stage of melanoma at the time of diagnosis.

Experts say that the skin cancer melanoma has become increasingly common in the last decade with incidence rates increasing 2.4 percent annually in the United States.

Because light-skinned individuals are at higher risk for melanoma, much of the prevention and early detection efforts have targeted white populations and this may explain improving survival rates which are up to 92 percent from 68 percent in the 1970 among whites.

However it appears such progress has not been seen among black and Hispanic populations.

A team from the University of Miami Miller School of Medicine reviewed 1,690 melanoma cases reported in Miami-Dade County between 1997 and 2002.

Of those cases 1,176 occurred in white patients, 485 in Hispanic patients and 29 in non-Hispanic black patients.

Dr. Shasa Hu, who led the study says they found that the Hispanic and black patients were both more likely to have advanced-stage melanomas than white patients.

It seems that of the melanoma patients reviewed 16 percent of Hispanics and 31 percent of blacks had cancer that had already spread to other organs and tissues at the time it was diagnosed, compared with 9 percent of whites.

Black patients had the highest rate, 52 percent, of regional- or distant-stage melanoma, the two most severe stages that indicate the cancer has spread to other lymph nodes or organs; compared to 26 percent for Hispanics and 16 percent for whites.

White patients were more likely to be diagnosed with earlier stages of melanoma, including melanoma in situ, or cases in which the cancer cells are found only in the outer layer of skin, and local melanoma, in which cancer has spread to the lower layers of skin but not to the surrounding lymph nodes.

Twenty-seven percent of white patients, 10 percent of black patients and 22 percent of Hispanic patients were diagnosed with melanoma in situ; 57 percent of white, 38 percent of black and 52 percent of Hispanic cases were diagnosed at the local stage.

The authors say the later diagnosis may contribute to lower survival rates among blacks and Hispanics and suggest that education, skin cancer screening and examinations need to be improved in these populations in order to improve melanoma survival rates in minority populations.

The report is published in the June issue of Archives of Dermatology.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site